Showing results (1381-1390 of 2,907) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|January 22, 2022
Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathwayZhengcun Wu, Chengxing Xia, Chao Zhang, et al.Cancer Gene Therapy|April 8, 2022
Harnessing Rift Valley fever virus NSs gene for cancer gene therapyAlicia M Davis, Tristan A Scott, Kevin V MorrisCancer Gene Therapy|May 3, 2022
The V-ATPases in cancer and cell deathFangquan Chen, Rui Kang, Jiao Liu, et al.Cancer Gene Therapy|April 22, 2022
Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1Yunfu Deng, Guangzhi Ma, Karin A Vallega, et al.Cancer Gene Therapy|July 15, 2022
Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4Tianzhen Hu, Chengyun Pan, Tianzhuo Zhang, et al.Cancer Gene Therapy|July 15, 2022
Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanismHe Shen, Yuwen Zhang, Elliot D Kramer, et al.Cancer Gene Therapy|May 15, 2023
Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesisPierre-Cyril Cômes, Tuan Le Van, Suzanne Tran, et al.Cancer Gene Therapy|April 10, 2023
Ewing sarcoma treatment: a gene therapy approachSergey Tsibulnikov, Daria Fayzullina, Irina Karlina, et al.Cancer Gene Therapy|August 22, 2020
LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1Yongzhi Li, Benkang Shi, Fengming Dong, et al.Cancer Gene Therapy|April 9, 2021
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemiasKuan-Wei Su, Da-Liang Ou, Yu-Hsuan Fu, et al.Pageof 291